DE69835519D1 - Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. - Google Patents

Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.

Info

Publication number
DE69835519D1
DE69835519D1 DE69835519T DE69835519T DE69835519D1 DE 69835519 D1 DE69835519 D1 DE 69835519D1 DE 69835519 T DE69835519 T DE 69835519T DE 69835519 T DE69835519 T DE 69835519T DE 69835519 D1 DE69835519 D1 DE 69835519D1
Authority
DE
Germany
Prior art keywords
diagnosis
compositions
treatment
iron
diseases associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69835519T
Other languages
English (en)
Other versions
DE69835519T2 (de
Inventor
N Feder
J Bjorkman
C Schatzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
California Institute of Technology CalTech
Original Assignee
Bio Rad Laboratories Inc
California Institute of Technology CalTech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc, California Institute of Technology CalTech filed Critical Bio Rad Laboratories Inc
Publication of DE69835519D1 publication Critical patent/DE69835519D1/de
Application granted granted Critical
Publication of DE69835519T2 publication Critical patent/DE69835519T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69835519T 1997-06-13 1998-06-12 Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind. Expired - Lifetime DE69835519T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87601097A 1997-06-13 1997-06-13
US876010 1997-06-13
PCT/US1998/012436 WO1998056814A1 (en) 1997-06-13 1998-06-12 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases

Publications (2)

Publication Number Publication Date
DE69835519D1 true DE69835519D1 (de) 2006-09-21
DE69835519T2 DE69835519T2 (de) 2007-04-05

Family

ID=25366786

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69835519T Expired - Lifetime DE69835519T2 (de) 1997-06-13 1998-06-12 Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
DE69841593T Expired - Lifetime DE69841593D1 (de) 1997-06-13 1998-06-12 Verfahren und Zusammensetzungen für die Diagnose und die Behandlung von Krankheiten, die mit Eisenüberschuss oder Eisenmangel assoziiert sind

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69841593T Expired - Lifetime DE69841593D1 (de) 1997-06-13 1998-06-12 Verfahren und Zusammensetzungen für die Diagnose und die Behandlung von Krankheiten, die mit Eisenüberschuss oder Eisenmangel assoziiert sind

Country Status (8)

Country Link
US (3) US6391852B1 (de)
EP (2) EP1757614B1 (de)
JP (1) JP2002506438A (de)
AT (2) ATE462717T1 (de)
AU (1) AU745403B2 (de)
CA (1) CA2293808C (de)
DE (2) DE69835519T2 (de)
WO (1) WO1998056814A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026116B1 (en) * 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US6849399B1 (en) * 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
US6391852B1 (en) 1997-06-13 2002-05-21 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
US6284732B1 (en) 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
US7160855B2 (en) * 2002-03-14 2007-01-09 Children's Hospital & Research Center At Oakland Enhancement of iron chelation therapy
US9982112B2 (en) 2010-02-19 2018-05-29 Dover Chemical Corporation Copolymeric polyphosphite polymer stabilizers
JP5771630B2 (ja) 2010-02-19 2015-09-02 ドーヴァー ケミカル コーポレイション アルキルフェノールを含まない液体高分子ホスファイトポリマー安定剤
US8981042B2 (en) 2010-02-19 2015-03-17 Dover Chemical Corporation Cycloaliphatic polyphosphite polymer stabilizers
US9745425B2 (en) 2012-06-22 2017-08-29 Dover Chemical Corporation Cycloaliphatic polyphosphite

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE208609C (de)
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US4711845A (en) 1984-08-31 1987-12-08 Cetus Corporation Portable temperature-sensitive control cassette
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
MX12394A (es) 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
IL84331A0 (en) 1987-11-02 1988-04-29 Yissum Res Dev Co Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same
EP0346281B1 (de) 1988-06-08 1992-06-17 Ciba-Geigy Ag Carbamoylierte Hydroxamsäurederivate und Verfahren zu ihrer Herstellung
US5116964A (en) 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5582979A (en) 1989-04-21 1996-12-10 Marshfield Clinic Length polymorphisms in (dC-dA)n.(dG-dT)n sequences and method of using the same
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
IL91047A (en) 1989-07-19 1993-06-10 Yissum Res Dev Co Zinc complexes for the treatment of free radical- induced diseases
US5607437A (en) 1990-07-12 1997-03-04 University Of Miami Instruments for use in performing gel injection adjustable keratoplasty
FR2680687A1 (fr) 1991-08-29 1993-03-05 Etienne Marie Christine Compositions pharmaceutiques homeopathiques utilisees pour la fabrication de medicaments destines au traitement des maladies causees par des erreurs metaboliques et au traitement des maladies virales.
WO1993011259A1 (en) 1991-12-02 1993-06-10 Oriental Yeast Co., Ltd. Method and reagent for determination of serum iron or unsaturated iron binding capacity
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
CA2139862C (en) 1992-07-10 2007-06-26 Wilfred A. Jefferies Use of p97 and iron binding proteins as diagnostic and therapeutic agents
AU5602594A (en) 1992-11-16 1994-06-08 University Of Florida Research Foundation, Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
EP0610745A3 (en) 1993-02-09 1994-09-28 Miles Inc Novel aminomethylene derivatives as immunosuppressants.
EP0610744B1 (de) 1993-02-09 1998-11-04 Bayer Corporation Sulfonamidaminomethylenderivate als Immunsuppressiva
US5385918A (en) 1993-02-09 1995-01-31 Miles Inc. Aminomethylene-peptides as immunosuppressants
AU3920293A (en) 1993-03-16 1994-10-11 Board Of Regents Of The University Of Nebraska, The Novel metal binding agents, and methods and compositions for their use to treat metal toxicity
JP3585180B2 (ja) 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
DE4327226A1 (de) 1993-08-13 1995-02-16 Hoechst Ag Chelatoren, ihre Herstellung aus den Antibiotika Salmycin A, B oder C und deren Verwendung
WO1995016663A1 (en) 1993-12-16 1995-06-22 Ciba-Geigy Ag N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
KR0136993B1 (ko) 1994-09-13 1998-04-24 김주용 비휘발성 메모리 소자 제조방법
US5674681A (en) 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis
US5705343A (en) 1995-05-08 1998-01-06 Mercator Genetics, Inc. Method to diagnose hereditary hemochromatosis
US5753438A (en) 1995-05-08 1998-05-19 Mercator Genetics, Inc. Method to diagnose hereditary hemochromatosis
US5712098A (en) 1996-04-04 1998-01-27 Mercator Genetics Hereditary hemochromatosis diagnostic markers and diagnostic methods
US6140305A (en) * 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US6025130A (en) 1996-04-04 2000-02-15 Mercator Genetics, Inc. Hereditary hemochromatosis gene
US5872237A (en) 1996-04-04 1999-02-16 Mercator Genetics, Inc. Megabase transcript map: novel sequences and antibodies thereto
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
EP1914319B1 (de) 1996-10-01 2014-11-12 Bio-Rad Laboratories, Inc. Polymorphismen im Bereich menschlicher Hämochromatose-Gene
US6391852B1 (en) 1997-06-13 2002-05-21 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
US6284732B1 (en) 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases

Also Published As

Publication number Publication date
EP0988316A4 (de) 2003-07-09
ATE335759T1 (de) 2006-09-15
EP1757614B1 (de) 2010-03-31
CA2293808C (en) 2006-10-17
US20060287236A1 (en) 2006-12-21
ATE462717T1 (de) 2010-04-15
AU745403B2 (en) 2002-03-21
US20030073627A1 (en) 2003-04-17
WO1998056814A1 (en) 1998-12-17
EP0988316B1 (de) 2006-08-09
US7119170B2 (en) 2006-10-10
EP0988316A1 (de) 2000-03-29
JP2002506438A (ja) 2002-02-26
AU7968198A (en) 1998-12-30
CA2293808A1 (en) 1998-12-17
EP1757614A1 (de) 2007-02-28
US7374892B2 (en) 2008-05-20
DE69835519T2 (de) 2007-04-05
US6391852B1 (en) 2002-05-21
DE69841593D1 (de) 2010-05-12

Similar Documents

Publication Publication Date Title
DE69536017D1 (de) Methoden und zusammensetzungen für die behandlung von glomerulonephritis
DE3686362D1 (de) Verfahren zur behandlung von magen-darmstoerungen.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE69835519D1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
PL350417A1 (en) Vascular adhesion molecules and modulation of their function
DE69729954D1 (de) Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
DE69329656D1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase-peptidantigenen exprimierenden zellen
FI913818A0 (fi) Nytt trombolytiskt aemne.
ATE454451T1 (de) Methode zur behandlung von muskelkrankheiten
ES2057572T3 (es) Agentes de reconocimiento.
DE69505376D1 (de) Alpha b crystallin zur verwendung in diagnose und therapie von autoimmunkrankheiten, besonders multipler skerose
DE59008012D1 (de) Mittel zur Behandlung von Leder und Pelzen.
ATE526995T1 (de) Stereoisomers von fettsäureanalogen für diagnostische bildgebung
DE69930545D1 (de) Verfahren zur diagnose und behandlung neurologischer erkrankungen
DE3766432D1 (de) Verfahren zur herstellung von c1- bis c6-n-alkylpyrrolidonen aus bernsteinsaeureanhydrid bzw. c1- bis c6-n-alkylsuccinimid.
PT870036E (pt) Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma
ATE352635T1 (de) Nukleotidsequenz, die für eine flavinmonooxygenase kodiert, das korrespondierende protein, sowie deren verwendungen in diagnostik und therapie
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen
ATE530651T1 (de) Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
DE69013139D1 (de) Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition